1. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118(12):2453-60.
2. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6):1134-46.
3. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch ophthalmol. 2011;129(5):545-53.
4. Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904-14.
5. Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica. 2012;228(2):110-16.
6. Pielen A, Feltgen N, Isserstedt C, Callizo J, Junker B, Schmucker C. Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review. PLoS One. 2013;25;8(10):e78538.
7. Meyer LM, Schönfeld CL. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up. J Ocul Pharmacol Ther. 2013;29(6):560-65.
8. Khurana RN, Appa SN, McCannel CA, Elman MJ, Wittenberg SE, Parks DJ, Ahmad S, Yeh S. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies. Ophthalmology. 2014;121(1):67-71.
9. Madi HA, Morgan SJ, Ghosh S. Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber. Am J Ophthalmol Case Rep. 2017;8:25-27.
10. Kang H, Lee MW, Byeon SH, Koh HJ, Lee SC, Kim M. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®). Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1819-25.
11. Pacella F, Agostinelli E, Carlesimo SC, Nebbioso M, Secondi R, Forastiere M, Pacella E. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report. J Med Case Rep. 2016;10(1):282.
12. Pardo-López D, Francés-Muñoz E, Gallego-Pinazo R, Díaz-Llopis M. Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®). Graefes Arch Clin Exp Ophthalmol. 2012;250(11):1703-4.
13. Bansal R, Bansal P, Kulkarni P, Gupta V, Sharma A, Gupta A. Wandering Ozurdex(®) implant. J Ophthalmic Inflamm Infect. 2012;2(1):1-5.
14. Szurman P, Petermeier K, Aisenbrey S, Spitzer MS, Jaissle GB. Z-suture: a new knotless technique for transscleral suture fixation of intraocular implants. Br J Ophthalmo. 2010;94:167-9.
15. Stepanov A, Codenotti M, Ramoni A, Prati M, Jiraskova N, Rozsival P, Bandello F. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient. Eur Joul Ophthalmol. 2016;26(3):e52-54.
16. Vela JI, Crespí J, Andreu D. Repostioning of dexamethasone implant (Ozurdex) migrated into the anterior chamber. Int Ophthalmol. 2012;32(6):583-4.
17. Akçay Bİ, Bozkurt TK, Güney E, Unlü C, Erdogan G, Akcali G, Bayramlar H. Quantitative analysis of macular thickness following uneventful and complicated cataract surgery. Clin Ophthalmol. 2012;6:1207-11
18. Chen WL, Lin CT, Yao CC, Huang YH, Chou YB, Yin HS, Hu FR. In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+-K+-ATPase activity of bovine corneal endothelial cells. Ocul Immunol Inflamm. 2006;14(4):215-3.
19. Kishore SA, Schaal S. Management of anterior chamber dislocation of dexamethasone implant. Ocul Immunol Inflamm. 2013;21(1):90-1.
20. Mateo C, Alkabes M. Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantation. Int Opthalmol. 2014;34:661-5.